D

dorc-dutch-ophthalmic-research-center-(international)

browser_icon
Company Domain www.dorcglobal.com link_icon
lightning_bolt Market Research

Market Research Report: DORC Dutch Ophthalmic Research Center



Company Overview



  • Name: DORC Dutch Ophthalmic Research Center (International)

  • Mission: To enhance global eye surgery by offering innovative approaches for eye disorders.

  • Founded: 1983

  • Founder: No information is available

  • Key People:

  • Pierre Billardon, CEO

  • David Dongwei Yang, Head of China, Managing Director - Eurazeo

  • Sjoerd de Gijzel

  • Henry Holster

  • Nilla Cijntje

  • Headquarters: Zuidland, Netherlands

  • Number of Employees: 501-1,000 employees

  • Revenue: No information is available

  • Known For: DORC is one of the world's leading suppliers of equipment, instruments, and liquids for ophthalmic surgery, providing solutions that maximize surgeon control, enhance surgical efficiency, and improve ease-of-use for surgical staff.


Products



Vitreoretinal



  • EVA NEXUS™: A highly intelligent ophthalmic surgical system that maintains stable intraocular pressure (IOP) during surgery with advanced features such as an infusion reversal function. Key components include:

  • Trocars

  • Vitrectomy cutters

  • Endoillumination

  • Laser probes

  • Microinjection

  • Diathermy


  • Instruments:

  • Microforceps

  • Microscissors

  • Backflush instruments

  • Membrane instruments

  • Other instruments


  • Surgical Liquids:

  • Surgical dyes

  • Surgical tamponades

  • Accessories


Cataract



  • EVA NEXUS™: Adapted for cataract surgery with features such as:

  • Phaco handpiece and tips


  • Instruments:

  • Irrigation/Aspiration

  • Cannulas

  • Cataract accessories


  • Surgical Liquids:

  • VisionBlue®


Other Ophthalmic



  • Cornea Instruments: Includes DMEK Disposable Surgical Set.


Recent Developments



  • New Products:

  • EVA INICIO™: Developed for EVA NEXUS™, the first approved ophthalmic microinjection system offering precise delivery and control of microinjections with pressure delivery of ±1 PSI.

  • EVA AVETA™: Trocar cannula system.

  • MEMBRANEBLUE-DUAL®: A staining solution for ILM & ERM.


  • Product Features:

  • VisionBlue®, trusted for over 9 million cataract surgeries, is the only trypan blue stain for anterior use approved by the FDA.

  • TDC VELOCE™: A two-dimensional cutter with speeds up to 16,000 cuts per minute (CPM).


  • Partnerships:

  • Collaboration with ZEISS Medical Technology to co-present solutions at AAO 2024 in Chicago, emphasizing surgical innovations and partnerships such as ZEISS ARTEVO® 850.


  • Events and Showcases:

  • Key participation in international events such as the American Academy of Ophthalmology (AAO) conferences and EURETINA 2024, focusing on the latest ophthalmic surgical technologies and collaborations.

  • Hosted symposia with experts sharing insights on surgical techniques and innovations.

  • Demonstrated the integration of AI-powered surgical insights using ZEISS Surgery Optimizer.


Contact Information



  • Locations:

  • Kerkweg 47e, Zuidland, 3214 VC, Netherlands

  • 10 Continental Drive, Bldg 1, Exeter, NH 03833, USA

  • 24 Rue Du Gouv General Félix Eboué, ISSY LES MOULINEAUX, 92130, France

  • Millhouse, 32-38 East Street, Rochford, Essex, SS4 1DB, UK


This professional report provides a comprehensive overview and recent developments of DORC Dutch Ophthalmic Research Center, a leader in the field of ophthalmic surgery. Further details on specific product functionalities and strategic partnerships with ZEISS emphasize DORC's pivotal role in advancing eye surgery techniques worldwide.
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI